EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic Potential of Periostin, Galectin-3 and Tenascin C Serum Measurements in Inflammatory Bowel Disease: Pilot Study

Aleksandra Górecka iD, Agnieszka Jura-Półtorak iD, Anna Szeremeta iD, Katarzyna Komosinska-Vassev iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Aleksandra Górecka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowi…. Hauptthemen laut MEDLINE: Tenascin, Cell Adhesion Molecules, Galectin 3, Inflammatory Bowel Diseases. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel diseases (IBD), encompassing ulcerative colitis (UC) and Crohn’s disease (CD), are characterized by a complex interplay between chronic inflammatory process and extracellular matrix (ECM) remodeling. This pilot study aims to evaluate the serum levels of three ECM-related proteins—periostin, galectin-3, and tenascin C—as biomarkers supporting IBD diagnosis. Serum concentration of periostin, galectin-3 and tenascin C were measured using the ELISA method in 49 patients with IBD and 30 healthy individuals. Periostin and galectin-3 levels differed significantly between IBD patients and healthy individuals, whereas tenascin C levels did not show a significant difference. The ROC curve analysis identified periostin as the most promising biomarker for differentiation of both UC and CD from healthy individuals. In UC patients, periostin distinguished them from healthy individuals with excellent accuracy (AUC = 0.922), high sensitivity (100%), and good specificity (77.8%). Similarly, in CD patients, periostin demonstrated excellent diagnostic performance with AUC of 0.943, high sensitivity (100%) and good specificity (77.8%). Galectin-3 also showed potential as a diagnostic marker, which discriminated both UC and CD patients with high accuracy of AUC = 0.745 in UC and AUC = 0.691 in CD groups. Moreover, serum galectin-3 levels correlated with CRP levels (r = 0.603, p < 0.05) in the CD group. After one year of conventional anti-inflammatory treatment in CD patients, levels of periostin (p < 0.001) and galectin-3 (p < 0.05) significantly decreased. In contrast UC patients, receiving anti-TNF-α biological therapy showed a significant increase in galectin-3 (p < 0.05) concentrations. Obtained results indicate that circulating periostin and galectin-3 emerge as promising biomarkers for differentiating both UC and CD patients from healthy individuals. Given the significant correlation between galectin-3 and CRP serum levels, galectin-3 may also serve as a useful marker for monitoring disease activity in CD. Furthermore, galectin-3 may be helpful in monitoring the response to both biological or conventional anti-inflammatory treatment in UC and CD patients. Periostin, in turn, may be particularly valuable for evaluating efficacy of conventional anti-inflammatory therapy in CD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TenascinCell Adhesion MoleculesGalectin 3Inflammatory Bowel DiseasesHumansMaleFemalePilot ProjectsAdultBiomarkersMiddle AgedROC CurveCase-Control StudiesCrohn DiseaseYoung AdultColitis, UlcerativeAgedPeriostinBlood ProteinsGalectins

Stichwörter der Autor:innen

Crohn’s diseasebiomarkerextracellular matrixgalectin-3inflammatory bowel diseaseperiostintenascin Culcerative colitis

Substanzen

TenascinPOSTN protein, humanCell Adhesion MoleculesGalectin 3BiomarkersLGALS3 protein, humanTNC protein, humanPeriostinBlood ProteinsGalectins

Autor:innen und Institutionen

  • Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland.

ORCID-Profile: Aleksandra Górecka, Agnieszka Jura-Półtorak, Anna Szeremeta, Katarzyna Komosinska-Vassev

Förderung

  • Medical University of Silesia

Zitieren

APA

Górecka, A., Jura-Półtorak, A., Szeremeta, A., & Komosinska-Vassev, K. (2025). Diagnostic Potential of Periostin, Galectin-3 and Tenascin C Serum Measurements in Inflammatory Bowel Disease: Pilot Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110439

Vancouver

Górecka A, Jura-Półtorak A, Szeremeta A, Komosinska-Vassev K. Diagnostic Potential of Periostin, Galectin-3 and Tenascin C Serum Measurements in Inflammatory Bowel Disease: Pilot Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110439

BibTeX
@article{Grecka2025,
  author = {Górecka, Aleksandra and Jura-Półtorak, Agnieszka and Szeremeta, Anna and Komosinska-Vassev, Katarzyna},
  title = {Diagnostic Potential of Periostin, Galectin-3 and Tenascin C Serum Measurements in Inflammatory Bowel Disease: Pilot Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110439}
}
Kostenlos starten →